FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
BILTRICIDE
praziquantel
LOE Approaching
Bayer
ORAL · TABLET
older for the treatment of the following infections: • Schistosomiasis due to all species of schistosoma (for exampleSchistosoma mekongi+7
1982
NDA30/100
BIOSCRUB
chlorhexidine gluconate
LOE Approaching
TOPICAL · SPONGE
1989
NDA30/100
BIPHETAMINE 12.5
amphetamine resin complex; dextroamphetamine resin complex
LOE Approaching
UCB Pharma
ORAL · CAPSULE, EXTENDED RELEASE
1955
NDA30/100
BIPHETAMINE 20
amphetamine resin complex; dextroamphetamine resin complex
LOE Approaching
UCB Pharma
ORAL · CAPSULE, EXTENDED RELEASE
1955
NDA30/100
BIPHETAMINE 7.5
amphetamine resin complex; dextroamphetamine resin complex
LOE Approaching
UCB Pharma
ORAL · CAPSULE, EXTENDED RELEASE
1955
NDA30/100
BLENOXANE
bleomycin sulfate
LOE Approaching
Bristol Myers Squibb
INJECTION · INJECTABLE
Lymphoma
1973
NDA30/100
BLEPHAMIDE
prednisolone acetate; sulfacetamide sodium
LOE Approaching
AbbVie
OPHTHALMIC · SUSPENSION
inflammatory conditions of the palpebralbulbar conjunctiva+8
1961
NDA30/100
BLOCADREN
timolol maleate
LOE Approaching
Merck & Co.
ORAL · TABLET
elevated intraocular pressure (IOP) in patients with open-angle glaucomaocular hypertension+2
1981
NDA30/100
BONIVA
ibandronate sodium
LOE Approaching
Roche
ORAL · TABLET
osteoporosis
2003
NDA30/100
BONIVA
ibandronate sodium
LOE Approaching
Roche
INTRAVENOUS · INJECTABLE
osteoporosis
2006
NDA30/100
BRANCHAMIN 4% IN PLASTIC CONTAINER
amino acids
LOE Approaching
Baxter
INJECTION · INJECTABLE
1984
NDA30/100
BREATHTEK UBT FOR H-PYLORI
urea c-13
LOE Approaching
Otsuka
ORAL · FOR SOLUTION
1996
NDA30/100
BRETHINE
terbutaline sulfate
LOE Approaching
ANI Pharmaceuticals
ORAL · TABLET
asthma
1976
NDA30/100
BRETHINE
terbutaline sulfate
LOE Approaching
Aspen Pharmacare
INJECTION · INJECTABLE
asthma
1981
NDA30/100
BRETYLIUM TOSYLATE
bretylium tosylate
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1986
NDA30/100
BRETYLIUM TOSYLATE
bretylium tosylate
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1986
NDA30/100
BRETYLIUM TOSYLATE IN DEXTROSE 5%
bretylium tosylate
LOE Approaching
Abbott
INJECTION · INJECTABLE
1986
NDA30/100
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
bretylium tosylate
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1986
NDA30/100
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
bretylium tosylate
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1986
NDA30/100
BREVIBLOC
esmolol hydrochloride
LOE Approaching
Baxter
INJECTION · INJECTABLE
noncompensatory sinus tachycardia wherethe physician's judgment+4
1986
NDA30/100
BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER
esmolol hydrochloride
LOE Approaching
Baxter
INJECTION · INJECTABLE
noncompensatory sinus tachycardia wherethe physician's judgment+4
1986
NDA30/100
BREVIBLOC IN PLASTIC CONTAINER
esmolol hydrochloride
LOE Approaching
Baxter
INJECTION · INJECTABLE
noncompensatory sinus tachycardia wherethe physician's judgment+4
1986
NDA30/100
BREVICON 21-DAY
ethinyl estradiol; norethindrone
LOE Approaching
AbbVie
ORAL-21 · TABLET
pregnancy
1974
NDA30/100
BREVICON 28-DAY
ethinyl estradiol; norethindrone
LOE Approaching
AbbVie
ORAL-28 · TABLET
pregnancy
1976
NDA30/100